Learn More
Thermo Scientific™ GeneBLAzer™ TRα-UAS-bla HEK 293T Assay Kit
Description
TR alpha-UAS-bla HEK 293T cells contain the ligand-binding domain (LBD) of the human Thyroid hormone receptor alpha(TR alpha) fused to the DNA-binding domain of GAL4 stably integrated in the GeneBLAzer™UAS-bla HEK 293T cell line. GeneBLAzer™UAS-bla HEK 293T cells stably express a beta-lactamase reporter gene under the transcriptional control of an upstream activator sequence (UAS). When an agonist binds to the LBD of the GAL4 (DBD)-TR alpha (LBD) fusion protein, the protein binds to the UAS, resulting in expression of beta-lactamase. TR alpha-UASbla HEK 293T 293 cells are functionally validated for Z' and EC50 concentrations of T3 Thryoid hormone. In addition, TR alpha-UAS-bla HEK 293T 293 cells have been tested for assay performance under variable conditions, including DMSO concentration, cell number, stimulation time, and substrate loading time (data available upon request). Additional testing data using alternate stimuli are also available.
Specifications
Specifications
| Alternate Agonists | 9-cis-retinoic acid, TTNPB, CD437, AM 580 |
| Antagonists | AGN 193109 |
| Assay Entry | Cell-based beta lactamase reporter gene |
| Cell State | Dividing Cells |
| Content And Storage | TR alpha-UAS-bla HEK 293T cells (K1260) Shipping: Dry Ice Storage:-80°C (liquid nitrogen) |
| Description | Primary Agonist: All-trans-retinoic Acid; Antagonists: AGN 193109; Reporter: BLA (Beta-Lactamase) |
| Detection Method | Fluorescence |
| For Use With (Application) | Nuclear Receptors |
| Includes | TR alpha-UAS-bla HEK 293T cells (K1260) |
| Primary Agonist | All-trans-retinoic Acid |
| Show More |
For Research Use Only. Not for use in diagnostic procedures.
Your input is important to us. Please complete this form to provide feedback related to the content on this product.